Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I.
about
Insulin-like growth factors in the gastrointestinal tract and liverDivergent metabolic adaptations to intestinal parasitic nematode infection in mice susceptible or resistant to obesityEffect of growth hormone on small intestinal homeostasis relation to cellular mediators IGF-I and IGFBP-3[Example of safety measures for antineoplastic agents immediately after market launch--a case of TS-1 capsule all example use result investigation that executes safety monitoring--].Endogenous nerve growth factor regulates collagen expression and bladder hypertrophy through Akt and MAPK pathways during cystitis.Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing.Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.Skeletal muscle catabolism in trinitrobenzene sulfonic acid-induced murine colitis.Dietary vegetable oils do not alter the intestine transcriptome of gilthead sea bream (Sparus aurata), but modulate the transcriptomic response to infection with Enteromyxum leei.Sleep quality, BDNF genotype and gene expression in individuals with chronic abdominal pain.Neurotrophin signaling and visceral hypersensitivityIn vivo regulation of brain-derived neurotrophic factor in dorsal root ganglia is mediated by nerve growth factor-triggered Akt activation during cystitisNew growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome.Tissue remodeling in eosinophilic esophagitisWound healing and fibrosis in intestinal disease.Immune-mediated signaling in intestinal goblet cells via PI3-kinase- and AKT-dependent pathways.Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitisA new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.Insulin-like growth factor 1: common mediator of multiple enterotrophic hormones and growth factors.The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine.Pre-protective effect of lipoic acid on injury induced by H2O2 in IPEC-J2 cells.Anti-TNFα alters the natural history of experimental Crohn's disease in rats when begun early, but not late, in disease.Benzoic acid beneficially affects growth performance of weaned pigs which was associated with changes in gut bacterial populations, morphology indices and growth factor gene expression.Morphological adaptation in adult short bowel syndrome undergoing intestinal rehabilitation.The pre-treatment characteristics and evaluation of the effects of recombinant human growth hormone therapy in children with growth hormone deficiency and celiac disease or inflammatory bowel disease.Infliximab reverses growth hormone resistance associated with inflammatory bowel disease
P2860
Q26998926-5CF32C11-3B1E-427F-BEB8-048CDD6355A1Q28756027-C265CDF2-6B18-4EBE-B0A3-7B3203952F12Q28854322-AE52ABC1-45AD-4F7E-A65F-F33F5927ABF6Q33369915-6A7C1033-F689-44D8-BDFA-8EB5EA2B69D7Q33662383-A939B219-9C2B-426E-9CB1-11F439977CFFQ33694525-1A806C71-11F3-48B0-87D1-28E363504E18Q33738131-B1104AEF-3FEC-4AB6-82DD-2591B1AB2D60Q34137976-92E7B2B0-DBF0-4F8A-AC22-EA20C6334D29Q34411253-5E1A8921-4CAC-4452-9B52-0EF06FC4ED7EQ34484879-975DED1E-A057-435C-B1C8-8F434E433253Q34626021-037D698E-04F0-4D54-B97B-230D68AB27D4Q35058604-BEDCE557-7064-49A8-918C-A18144745A33Q36489336-81D60E03-FCDA-4331-B872-8E416DB5B27DQ36494364-FC41FA0B-0507-4DFA-9565-BE665B2CBCF7Q36685523-9E2553AD-73F1-48FF-812A-926DCCE571ECQ36977078-EAE4D3AE-EB46-4328-9D10-7BB8EDF9F88EQ37227780-B72241C9-24A3-4CE3-8889-EFCAE9FE7A57Q37363427-B90AE899-8E4F-4FCD-B8C1-14D3D833BC6EQ37975414-A75B665B-7B95-47D7-8DF5-10217950BD76Q38101129-63393ABB-E13E-4659-B1AC-59D10447EB9FQ38920040-32794C94-A2E0-4BDE-9D3E-2F957AFC3DEAQ39188721-757CBEDA-4249-4CEE-B0B4-C19DAA8F35ADQ39453169-3E46EA3F-4C12-4247-A10A-7F50D16763F8Q51387461-B25F8C0F-3318-4D0A-BDAB-29B1F72ACFD0Q53121089-80181A1C-3CCA-463F-8659-DD1FEA01A690Q54939588-49D0443B-41DB-4561-873E-2EF8F8010504Q59310001-CF2EE0DF-B58E-48CE-870C-2ABAEF05BF97
P2860
Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Growth factors in inflammatory ...... insulin-like growth factor-I.
@ast
Growth factors in inflammatory ...... insulin-like growth factor-I.
@en
type
label
Growth factors in inflammatory ...... insulin-like growth factor-I.
@ast
Growth factors in inflammatory ...... insulin-like growth factor-I.
@en
prefLabel
Growth factors in inflammatory ...... insulin-like growth factor-I.
@ast
Growth factors in inflammatory ...... insulin-like growth factor-I.
@en
P2093
P2860
P1476
Growth factors in inflammatory ...... insulin-like growth factor-I.
@en
P2093
Arianne L Theiss
P Kay Lund
Shira Fruchtman
P2860
P304
P356
10.1097/00054725-200411000-00021
P577
2004-11-01T00:00:00Z